Community/Retail

New research reveals PUF60's critical role in triple-negative breast cancer, highlighting RNA splicing as a promising therapeutic target for oncology.

Dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists were found to offer neuroprotective effects to patients who were administered the medications.

Ali Dehghani, DO, highlights that shingles vaccination not only prevents rash but is also associated with lower risks of major cardiovascular events, dementia, and mortality, underscoring pharmacists’ role in patient counseling and preventive care.

The FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D).

Innovative digital twin technology revolutionizes brain cancer treatment by predicting tumor metabolism and personalizing therapies for better patient outcomes.

High out-of-pocket costs lead patients to skip medications. Financial assistance programs improve adherence, but complex insurance strategies may hinder access.

The glucagon-like peptide-1 (GLP-1) receptor agonist medications evaluated included semaglutide, tirzepatide, and liraglutide.

Nina Masters, PhD, MPH, explains how early adherence to pediatric vaccines strongly predicts timely measles-mumps-rubella (MMR) vaccination.

Food insecurity and social instability significantly increase long COVID risk in children, highlighting the need for targeted public health interventions.

A tour through GLP-1’s unexpected biology.

Polypharmacy poses significant risks for patients, highlighting the need for comprehensive medication reviews and patient involvement.

According to the news release, the manufacturers have 30 days to respond.

Jeffery A. Goad, PharmD, MPH, stresses that consistent, evidence-based communication from pharmacists and other health care professionals is essential to maintaining public trust and preventing declines in childhood vaccination.

Explore the differences between oral and injectable semaglutide for weight management, focusing on adherence, adverse effects, and patient preferences.

AbbVie partners with the Trump administration to enhance drug affordability and access, committing to significant investments in US pharmaceutical innovation.

Recombinant zoster vaccination against shingles significantly reduced the risk of heart disease and dementia, even after a prior case of shingles.

New research reveals a gut bacteria-derived molecule that enhances lung cancer immunotherapy, potentially improving outcomes for patients with limited treatment options.

Pharmacists enhancing patient care through medication optimization, screenings, and interprofessional collaboration.

Research reveals how eczema's timing and severity influence children's chances of outgrowing food allergies, highlighting the connection between skin health and allergy tolerance.

Jeffery A. Goad, PharmD, MPH, explains how the shift toward shared clinical decision-making for pediatric vaccines may complicate counseling, reduce vaccine uptake, and increase public health risks.

Pitavastatin shows promise as a novel treatment for triple-negative breast cancer, enhancing chemotherapy efficacy and targeting cancer cell survival pathways.

Dave Berkus’s quip might define the most significant transition in buying and selling medications since the inception of pharmacy benefit managers.

Start 2026 with clear goals, smart planning, and intentional action.

The findings reemphasize a need for mental health support for those in the pharmacy profession.

Pharmacists play a vital role in mental health care, enhancing treatment continuity and bridging gaps between mental and physical health for patients with serious mental illness.

Recently released guidelines enhance chronic kidney disease management, emphasizing early detection and innovative treatments for better patient outcomes.

The FDA approves Naox Link, a groundbreaking in-ear EEG device, transforming brain monitoring and enhancing neurologic care for patients and pharmacists.

Long-term type 2 diabetes significantly increases cardiovascular disease risk, revealing potential biomarkers for early intervention and prevention strategies.